-Tehelka Justice Sujata Manohar on how the Biotechnology Bill is fundamentally flawed IN THE last few years, regulatory systems across the board have been undergoing an overhaul to fit the needs of a new era. Likewise, new laws are being chalked out to meet new needs, and several are receiving flak owing to the loopholes and regressive grounds on which these have been drafted. The relatively more recent one to regulate modern...

-The Sunday Indian  When I first heard about two journalists battling for life after returning from a reporting assignment in the Abujmarh jungles of Chattisgarh, from a journalist friend, I was left unmoved. In journalistic circles, while we haven't yet lost on our emotions, it's a proud feeling to see a fellow journalist excel at reportage from an inaccessible corner, especially when the reporter is still a cub in the field....

A 26-year-old man from Hooghly who lost his tongue to cancer in a Mumbai hospital last week has lent his voice to a public health campaign urging the Bengal government to ban the sale of gutka laced with tobacco. Mantu Mahato, who was diagnosed with advanced tongue cancer earlier this year, five years after he started chewing gutka, has written a letter to chief minister Mamata Banerjee urging her to ban...

Jatav residents of Ramgarh in U.P. resist attempts by members of a powerful community to grab their land by violent means. IN what could be considered one of the worst incidents of vendetta against Dalits in the National Capital Region (NCR), members of the Dalit Jatav community were beaten up brutally by some members of the dominant Gujjar community in Ramgarh village in the Greater Noida area of Uttar Pradesh...

A key finding in the report was that several multinational firms had launched drugs without conducting mandatory clinical trials or seeking expert medical opinion The health ministry has denied the presence of any systemic rot in the drug approval process and pharmaceutical firms have refuted charges of collusion after a report by a parliamentary panel pointed to regulatory lapses in clinical trials. The panel, which looked into the functioning of Central Drugs...